CSE: TRUE OTC: TREIF 939: FRA
CSE: TRUE OTC: TREIF 939: FRA

Treatment Announces Convertible Debenture Private Placement

VANCOUVER, British Columbia, March 28, 2022 (GLOBE NEWSWIRE) — Treatment.com International Inc. (“Treatment or the “Company”) (CSE: TRUE; OTC: TREIF; FFA: 939), a global healthcare company that has developed a next-generation AI platform to help patients and caregivers around the world make better health decisions, announces the proceeding of a non-brokered private placement, raising aggregate […]

Treatment Appoints Drew Zimmerman to its Board of Directors

Vancouver, B.C. March 7, 2022 – Treatment.com International Inc. (“Treatment” or the “Company”) (CSE: TRUE; OTC: TREIF; FFA 939), a global healthcare technology company that has developed a next generation AI platform to help patients and caregivers around the world make better health decisions, is pleased to announce the appointment of Mr. Drew Zimmerman to the […]